Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-12,478
Closed -$517K 863
2019
Q4
$517K Sell
12,478
-7,539
-38% -$317K 0.03% 840
2019
Q3
$916K Buy
+20,017
New +$872K 0.05% 592
2019
Q2
Sell
-7,195
Closed -$313K 1608
2019
Q1
$313K Sell
7,195
-2,095
-23% -$107K 0.02% 925
2018
Q4
$439K Sell
9,290
-10,057
-52% -$603K 0.03% 784
2018
Q3
$1.44M Buy
19,347
+12,500
+183% +$861K 0.07% 415
2018
Q2
$377K Buy
+6,847
New +$316K 0.02% 1018
2015
Q4
Sell
-15,438
Closed -$337K 1696
2015
Q3
$337K Buy
+15,438
New +$362K 0.01% 1009
2013
Q3
Sell
-23,557
Closed -$471K 1478
2013
Q2
$471K Buy
+23,557
New +$590K 0.02% 900

Other funds holding SRDX

A.R.T. Advisors's SRDX Position: Q1 2020 in Review

A.R.T. Advisors sold out of Surmodics (SRDX) in Q1 2020, closing a stake of 12,478 shares — an estimated $517K sold.

A.R.T. Advisors first reported a position in SRDX in Q2 2013 and held it in 8 quarters. The position peaked at $1.44M in Q3 2018. 127 funds tracked by Wall St. Rank hold SRDX as of Q1 2020.

  • A.R.T. Advisors reported no remaining Surmodics position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 12,478 Surmodics shares in Q1 2020, an estimated $517K.
  • A.R.T. Advisors first reported a position in Surmodics in Q2 2013 and held it in 8 quarters.
  • A.R.T. Advisors's Surmodics position peaked at $1.44M in Q3 2018.
  • 127 funds tracked by Wall St. Rank held Surmodics as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.